Specialty Pharmacy Times
October 2020
Volume: 3
Issue: 3
June 2020
Volume: 3
Issue: 2
February 2020
Volume: 3
Issue: 1
September/October 2019
Volume: 11
Issue: 6
July/August
Volume: 10
Issue: 5
2019 Asembia Recap
Volume: 10
Issue: 4
May/June
Volume: 10
Issue: 3
March/April
Volume: 10
Issue: 2
January/February
Volume: 10
Issue: 1
November/December
Volume: 9
Issue: 7
September/October
Volume: 9
Issue: 6
July/August
Volume: 9
Issue: 5
2018 Asembia Recap
Volume: 9
Issue: 4
May/June
Volume: 9
Issue: 3
March/April
Volume: 9
Issue: 2
January/February
Volume: 9
Issue: 1
November/December
Volume: 8
Issue: 7
2017
Volume: 5
Issue: 1
September/October
Volume: 8
Issue: 6
July/August 2017
Volume: 8
Issue: 5
2017 Asembia Recap
Volume: 8
Issue: 4
May/June 2017
Volume: 8
Issue: 3
March/April 2017
Volume: 8
Issue: 2
January/February 2017
Volume: 8
Issue: 1
November/December 2016
Volume: 7
Issue: 6
2016
Volume: 4
Issue: 1
September/October 2016
Volume: 7
Issue: 5
July/August 2016
Volume: 7
Issue: 4
May/June 2016
Volume: 7
Issue: 3
March/April 2016
Volume: 7
Issue: 2
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
3
Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety
4
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
5
